TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014
TCL Archive New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program October 24, 1975
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012